FLORA PALMER-IKUKU: Open Payments
NPI 1508577537 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,098 in 88 payments from 26 companies in 2025. Trend: 2023 $697 · 2024 $2,046 · 2025 $2,098
Food & beverage: $2,098
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $652 |
| ARGENX US, INC. | 5 | $162 |
| Merz Pharmaceuticals, LLC | 6 | $139 |
| SK Life Science, Inc. | 5 | $135 |
| UCB, Inc. | 4 | $117 |
| Globus Medical, Inc. | 1 | $92 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $86 |
| Otsuka America Pharmaceutical, Inc. | 4 | $76 |
| ACADIA Pharmaceuticals Inc | 3 | $71 |
| Axsome Therapeutics, Inc. | 3 | $61 |
Products named: BOTOX, QULIPTA, VYVGART HYTRULO, UBRELVY, Xeomin, Rystiggo, REXULTI, SENZA.
Industry payments across TX — which companies pay providers there.
